Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04640259 · ClinicalTrials.gov registry record
Epidemiology of Young Lung Cancer - Survey
A clinical trial of NSCLC, sponsored by Addario Lung Cancer Medical Institute.
- Active
- Registry status
- 250
- Enrollment target
- 2
- Study locations
NCT04640259 is a study of NSCLC that is active but no longer recruiting, run by Addario Lung Cancer Medical Institute. The registered enrollment target is 250 participants, above the 220-participant average among 71 other NSCLC trials with a reported enrollment target (14% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT04640259, a study of NSCLC, is active but no longer recruiting, sponsored by Addario Lung Cancer Medical Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a 100% virtual (remote), case-case study to explore potential environmental, lifestyle and genetic factors that may be associated with driver mutations of young lung cancer in the U.S.
Conditions Studied
Interventions
- OTHER Online Survey
Study Locations (2)
California
- USC Keck School of Medicine - Los Angeles
- Addario Lung Cancer Medical Institute - San Carlos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2026-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04640259
The ClinicalTrials.gov registry entry for NCT04640259 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 220-participant average among 71 other NSCLC trials with a reported enrollment target (14% higher). The listed sponsor is Addario Lung Cancer Medical Institute, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with NSCLC appearing as the primary indexed condition, and to 1 intervention - of which Online Survey is the first listed.
NCT04640259 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04640259 about?
NCT04640259 is a clinical study titled "Epidemiology of Young Lung Cancer - Survey". This is a 100% virtual (remote), case-case study to explore potential environmental, lifestyle and genetic factors that may be associated with driver mutations of young lung cancer in the U.S.
What is the current status of trial NCT04640259?
This trial is currently active not recruiting. The enrollment target is 250 participants. The study started on 2021-02-01. Estimated completion is 2026-03.
What conditions does trial NCT04640259 study?
This clinical trial studies the following conditions: NSCLC.
What interventions are being tested in trial NCT04640259?
The interventions under investigation include: Online Survey (OTHER).
Who is sponsoring clinical trial NCT04640259?
This trial is sponsored by Addario Lung Cancer Medical Institute, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04640259 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for NSCLC
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of EP0031 in Patients With Advanced RET-altered Malignancies
RECRUITING · Phase 1
-
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RECRUITING · Phase 1
-
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
RECRUITING · Phase 1
-
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
RECRUITING · Phase 2
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.